Tectonic Therapeutic Inc
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
TECX$20.64+6.3%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS
| June 30, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| (unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $185,124 | $28,769 |
| Prepaid expenses and other current assets | 2,264 | 2,115 |
| Total current assets | 187,388 | 30,884 |
| Property, equipment and improvements, net | 2,639 | 3,122 |
| Finance right-of-use assets, net | 1,208 | 1,437 |
| Operating right-of-use assets | 2,075 | 2,669 |
| Deferred offering costs | — | 669 |
| Restricted cash | 587 | 587 |
| Other assets | 13 | 31 |
| Total assets | $193,910 | $39,399 |
| Liabilities, Convertible Preferred Stock and Stockholders’ Equity (Deficit) | ||
| Current liabilities: | ||
| Accounts payable | $4,090 | $409 |
| Accrued expenses and other current liabilities | 20,009 | 8,141 |
| SAFE liabilities | — | 30,515 |
| Operating lease liability - current portion | 1,428 | 1,348 |
| Finance lease liability - current portion | 474 | 475 |
| Total current liabilities | 26,001 | 40,888 |
| Operating lease liability - net of current portion | 905 | 1,644 |
| Finance lease liability - net of current portion | 637 | 876 |
| Total liabilities | 27,543 | 43,408 |
| Commitments and contingencies (Note 7) | ||
| Convertible preferred stock (Series A-1, A-2, A-3 and A-4), $0.0001 par value; 6,825,483 shares authorized as of December 31, 2023; 6,825,483 shares issued and outstanding as of December 31, 2023; aggregate liquidation preference of $87,459 as of December 31, 2023 | — | 80,627 |
| Stockholders’ Equity (Deficit): | ||
| Common stock, $0.0001 par value; 150,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 14,734,323 and 2,634,246 shares issued and outstanding as of June 30, 2024 and December 31, 2023 | 2 | — |
| Additional paid-in capital | 284,922 | 5,979 |
| Accumulated other comprehensive loss | (61) | (11) |
| Accumulated deficit | (118,496) | (90,604) |
| Total stockholders’ equity (deficit) | 166,367 | (84,636) |
| Total liabilities, convertible preferred stock and stockholders’ equity (deficit) | $193,910 | $39,399 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.